Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events

European Heart Journal

Volumn 31, Issue 12, 2010, Pages 1449-1456

  López Sendón, José ^a   Gurfinkel, Enrique P ^b   Lopez De Sa, Esteban ^a   Agnelli, Giancarlo ^c   Gore, Joel M ^d   Steg, Phillippe Gabriel ^e   Eagle, Kim A ^f   Cantador, Jose Ruiz ^a   Fitzgerald, Gordon ^d   Granger, Christopher B ^g  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e INSERM   (France)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute coronary syndromes; Beta blockers; Heart rupture; Primary percutaneous coronary intervention; Reperfusion therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GROUPS BY AGE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HEART VENTRICLE SEPTUM RUPTURE; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTOLIC BLOOD PRESSURE; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGINA, UNSTABLE; ANTICOAGULANTS; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEART RUPTURE; HEART RUPTURE, POST-INFARCTION; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; YOUNG ADULT;

EID: 77953763730     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq061     Document Type: Article

References (45)

1. Bates RJ, Beutler S, Resnekov L, Anagnostopoulos CE. Cardiac rupture-challenge in diagnosis and management. Am J Cardiol 1977;40:429-437.
2. Dellborg M, Held P, Swedberg K, Vedin A. Rupture of the myocardium. Occurrence and risk factors. Br Heart J 1985;54:11-16.
3. Figueras J, Alcalde O, Barrabes JA, Serra V, Alguersuari J, Cortadellas J, Lidon RM. Changes in hospital mortality rates in 425 patients with acute ST-elevation myo-cardial infarction and cardiac rupture over a 30-year period. Circulation 2008;118: 2783-2789.
4. Perdigao C, Lopez-Sendon J, Froufe J, Andrade A, Gamallo C, Bilbao F, Jadraque LM, Ribeiro C. [Causes of death in acute myocardial infarct. Iberic multi-center study]. Rev Port Cardiol 1988;7:31-35.
5. Becker RC, Charlesworth A, Wilcox RG, Hampton J, Skene A, Gore JM, Topol EJ. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995;25:1063-1068.
6. Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, Tiefenbrunn AJ, Bowlby LJ, Rogers WJ. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996;27:1321-1326.
7. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ; GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Risk factors, angio-graphic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 2000;101:27-32.
8. Moreno R, Lopez-Sendon J, Garcia E, Perez de Isla L, Lopez de Sa E, Ortega A, Moreno M, Rubio R, Soriano J, Abeytua M, Garcia-Fernandez MA. Primary angio-plasty reduces the risk of left ventricular free wall rupture compared with throm-bolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002;39: 598-603.
9. Gonzalez Pacheco H. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes]. Arch Cardiol Mex 2001;71(Suppl. 1): S63-S68.
10. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163:2345-2353.
11. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr, Anbe DT, Kushner FG, Ornato JP, Pearle DL, Sloan MA, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;51:210-247.
12. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Silber S, Aguirre FV, Al-Attar N, Alegria E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GY, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
13. Stevenson WG, Linssen GC, Havenith MG, Brugada P, Wellens HJ. The spectrum of death after myocardial infarction: a necropsy study. Am Heart J 1989;118: 1182-1188.
14. Lopez-Sendon J, Gonzalez A, Lopez de Sa E, Coma-Canella I, Roldan I, Dominguez F, Maqueda I, Martin Jadraque L. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992;19: 1145-1153.
15. Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ. Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005;96:611-616.
16. Gueret P, Khalife K, Jobic Y, Fillipi E, Isaaz K, Tassan-Mangina S, Baixas C, Motreff P, Meune C. Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfu-sion era: a French multicentre prospective registry. Arch Cardiovasc Dis 2008;101: 41-47.
17. Nakatani D, Sato H, Kinjo K, Mizuno H, Hishida E, Hirayama A, Mishima M, Ito H, Matsumura Y, Hori M. Effect of successful late reperfusion by primary coronary angioplasty on mechanical complications of acute myocardial infarction. Am J Cardiol 2003;92:785-788.
18. Nishiyama K, Okino S, Andou J, Nakagawa Y, Kimura T, Nobuyoshi M. Coronary angioplasty reduces free wall rupture and improves mortality and morbidity of acute myocardial infarction. J Invasive Cardiol 2004;16:554-558.
19. Yamaguchi J, Kawaguchi M, Kawana M, Asano R, Sumiyoshi T, Kasanuki H. Risk factors and effect of reperfusion therapy on left ventricular free wall rupture following acute myocardial infarction. J Cardiol 2000;35:257-265.
20. Poulsen SH, Praestholm M, Munk K, Wierup P, Egeblad H, Nielsen-Kudsk JE. Ventricular septal rupture complicating acute myocardial infarction: clinical characteristics and contemporary outcome. Ann Thorac Surg 2008;85:1591-1596.
21. Sakaguchi G, Komiya T, Tamura N, Kobayashi T. Surgical treatment for postinfarc-tion left ventricular free wall rupture. Ann Thorac Surg 2008;85:1344-1346.
22. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, Dzavik V, Greenberg M, Menegus M, Connery C, Hochman JS. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36:1117-1122.
23. Terashima M, Fujiwara S, Yaginuma GY, Takizawa K, Kaneko U, Meguro T. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction. Am J Cardiol 2008;101:419-421.
24. Lopez Sendon J, Lopez de Sa E, Moreno R, Delcan JL. [Heart rupture after acute myocardial infarction. It is more frequent in women?] Rev Port Cardiol 1999; 18(Suppl. 3):III17-19.
25. Bueno H, Martinez-Selles M, Perez-David E, Lopez-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J 2005;26:1705-1711.
26. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993;329: 1442-1448.
27. Perdigao C, Sendon JL, Monteiro J, Andrade A, Ribeiro C. [Coronary thrombosis in patients who have died of acute myocardial infarct. A clinico-anatomical study of 167 successive cases]. Rev Port Cardiol 1993;12:617-622; 599-600.
28. Pretre R, Rickli H, Ye Q, Benedikt P, Turina MI. Frequency of collateral blood flow in the infarct-related coronary artery in rupture of the ventricular septum after acute myocardial infarction. Am J Cardiol 2000;85:497-499; A410.
29. Ohman EM, Topol EJ, Califf RM, Bates ER, Ellis SG, Kereiakes DJ, George BS, Samaha JK, Kline E, Sigmon KN, Stack RS; the Thrombolysis Angioplasty in Myo-cardial Infarction Study Group An analysis of the cause of early mortality after administration of thrombolytic therapy. Coron Artery Dis 1993;4:957-964.
30. Amery A, Roeber G, Vermeulen HJ, Verstraete M. Single-blind randomised multi-centre trial comparing heparin and streptokinase treatment in recent myocardial infarction. Acta Med Scand Suppl 1969;505:1-35.
31. Heikinheimo R, Ahrenberg P, Honkapohja H, Iisalo E, Kallio V, Konttinen Y, Leskinen O, Mustaniemi H, Reinikainen M, Siitonen L. Fibrinolytic treatment in acute myocardial infarction. Acta Med Scand 1971;189:7-13.
32. Okino S, Nishiyama K, Ando K, Nobuyoshi M. Thrombolysis increases the risk of free wall rupture in patients with acute myocardial infarction undergoing percutaneous coronary intervention. J Interv Cardiol 2005;18:167-172.
33. European Working Party. Streptokinase in recent myocardial infarction: a controlled multicentre trial. Br Med J 1971;3:325-331.
34. European Cooperative Study Group for Streptokinase Treatment in Acute Myo-cardial Infarction. Streptokinase in acute myocardial infarction. N Engl J Med 1979; 301:797-802.
35. Honan MB, Harrell FE Jr, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-367.
36. Yip HK, Fang CY, Tsai KT, Chang HW, Yeh KH, Fu M, Wu CJ. The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction. Chest 2004;125:1622-1628.
37. Yip HK, Wu CJ, Chang HW, Wang CP, Cheng CI, Chua S, Chen MC. Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era. Chest 2003;124:565-571.
38. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
39. Pollak H, Mlczoch J. Effect of nitrates on the frequency of left ventricular free wall rupture complicating acute myocardial infarction: a case-controlled study. Am Heart J 1994;128:466-471. (Pubitemid 24298297)
40. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet 1988;1:921-923.
41. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-1900.
42. Zahger D, Milgalter E, Pollak A, Hasin Y, Merin G, Beeri R, Gotsman MS. Left ventricular free wall rupture as the presenting manifestation of acute myocardial infarction in diabetic patients. Am J Cardiol 1996;78:681-682.
43. Nahrendorf M, Hu K, Frantz S, Jaffer FA, Tung CH, Hiller KH, Voll S, Nordbeck P, Sosnovik D, Gattenlohner S, Novikov M, Dickneite G, Reed GL, Jakob P, Rosenzweig A, Bauer WR, Weissleder R, Ertl G. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation 2006;113:1196-1202.
44. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007;43:535-544.
45. Fang L, Gao XM, Samuel CS, Su Y, Lim YL, Dart AM, Du XJ. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocar-dial infarction. Clin Sci (Lond) 2008;115:99-106.